Pediatric Hypothyroidism: Clinical Manifestations, Growth Impairment, and Levothyroxine Management
Pediatric hypothyroidism represents a critical endocrine priority because thyroid hormones govern neonatal neurodevelopment, myelination, and childhood epiphyseal linear bone growth. Pathology is divided into congenital hypothyroidism (targeted by neonatal screening heel-prick programs) and acquired hypothyroidism (predominantly juvenile autoimmune Hashimoto's thyroiditis). This clinical guide explores age-dependent symptomatology, bone age radiologic delays, neurocognitive preservation, and weight-adjusted pediatric levothyroxine titration.